The Cancer and Blood Diseases Institute at Cincinnati Children’s is a national leader in caring for children and young adults with cancer. Our cancer program is ranked No. 1 in the nation by U.S. News & World Report.
The director of the Division of Oncology is John Perentesis, MD, a nationally recognized expert in the development of anticancer drugs for children and young adults. His leadership roles have included the National Cancer Institute's Investigational Drug Steering Committee, the Neurofibromatosis Consortium Drug Development and Executive Committees, the Myeloid Leukemia Relapse Committee and the Adolescent / Young Adult Cancer Committee of the Children's Oncology Group. Perentesis and our experienced specialists offer the most advanced therapies for patients who are newly diagnosed, and those seeking innovative treatments for rare, relapsed and recurrent cancers.
The doctors work closely with nurses, social workers and other members of the care team to provide early, accurate diagnoses, appropriate medical treatment, family support and patient education. The team strives to help patients maintain a “normal” life by helping them keep up in school and providing treatment on an outpatient (rather than inpatient) basis whenever possible.